Concord Biotech Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
---|---|---|---|---|---|
Debt-Equity Ratio | 0.01 | 0.04 | 0.07 | 0.08 | 0.04 |
Long Term Debt-Equity Ratio | 0.00 | 0.02 | 0.04 | 0.05 | 0.03 |
Current Ratio | 3.21 | 2.95 | 3.44 | 3.17 | 2.90 |
Fixed Assets | 1.26 | 1.13 | 1.05 | 1.29 | 1.73 |
Inventory | 4.84 | 4.19 | 4.09 | 4.66 | 5.05 |
Debtors | 3.26 | 3.37 | 3.48 | 3.42 | 3.00 |
Interest Cover Ratio | 129.68 | 62.79 | 40.34 | 299.25 | 163.43 |
PBIDTM (%) | 45.82 | 44.45 | 41.71 | 55.39 | 41.47 |
PBITM (%) | 40.55 | 38.12 | 34.69 | 50.93 | 37.32 |
PBDTM (%) | 45.51 | 43.85 | 40.85 | 55.22 | 41.24 |
CPM (%) | 35.24 | 34.24 | 32.07 | 42.61 | 33.72 |
APATM (%) | 29.97 | 27.91 | 25.05 | 38.14 | 29.57 |
ROCE (%) | 28.81 | 26.05 | 21.86 | 32.82 | 25.21 |
RONW (%) | 21.63 | 19.85 | 16.95 | 26.59 | 20.86 |